Ledger.Open graph →

SEC Form D · filed August 1, 2024

Autobahn Therapeutics, Inc

Offering

$120.0M

Sold

$100.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Justin W. Banulski · SAN FRANCISCO, CADirector Bonnie J. Van Wilgenburg · San Diego, CADirector Timothy Anderson · Boca Raton, FLDirector Uwe J. Schoenbeck · San Diego, CADirector Kevin Finney · Campbell, CAExec · Director Scott Giacobello · Pacific Palisades, CADirector Timothy Anderson · San Diego, CADirector Benjamin Cravatt · San Diego, CADirector Thomas Cahill · San Diego, CADirector Kevin Finney · San Diego, CAExec · Director Kristina D. Burow · San Diego, CADirector John Borkholder · Santa Clara, CAExec Kristina D. Burow · San Diego, CADirector John Borkholder · San Diego, CAExec Bonnie J. Van Wilgenburg · San Diego, CADirector Philip J. Desouza · San Diego, CADirector Benjamin Cravatt · San Diego, CADirector Uwe J. Schoenbeck · San Diego, CADirector Philip J. Desouza · San Diego, CADirector Thomas Cahill · San Diego, CADirector Scott Giacobello · Pacific Palisades, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗